BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17476974)

  • 1. Expression of NEU3 (plasma membrane-associated sialidase) in clear cell adenocarcinoma of the ovary: its relationship with T factor of pTNM classification.
    Nomura H; Tamada Y; Miyagi T; Suzuki A; Taira M; Suzuki N; Susumu N; Irimura T; Aoki D
    Oncol Res; 2006; 16(6):289-97. PubMed ID: 17476974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ALDH1-high ovarian cancer stem-like cells can be isolated from serous and clear cell adenocarcinoma cells, and ALDH1 high expression is associated with poor prognosis.
    Kuroda T; Hirohashi Y; Torigoe T; Yasuda K; Takahashi A; Asanuma H; Morita R; Mariya T; Asano T; Mizuuchi M; Saito T; Sato N
    PLoS One; 2013; 8(6):e65158. PubMed ID: 23762304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy.
    Wu RC; Ayhan A; Maeda D; Kim KR; Clarke BA; Shaw P; Chui MH; Rosen B; Shih IeM; Wang TL
    J Pathol; 2014 Mar; 232(4):473-81. PubMed ID: 24338723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NEU1 and NEU3 sialidase activity expressed in human lung microvascular endothelia: NEU1 restrains endothelial cell migration, whereas NEU3 does not.
    Cross AS; Hyun SW; Miranda-Ribera A; Feng C; Liu A; Nguyen C; Zhang L; Luzina IG; Atamas SP; Twaddell WS; Guang W; Lillehoj EP; Puché AC; Huang W; Wang LX; Passaniti A; Goldblum SE
    J Biol Chem; 2012 May; 287(19):15966-80. PubMed ID: 22403397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of the RIalpha subunit of the cAMP-dependent protein kinase A is associated with advanced stage ovarian cancer.
    McDaid HM; Cairns MT; Atkinson RJ; McAleer S; Harkin DP; Gilmore P; Johnston PG
    Br J Cancer; 1999 Feb; 79(5-6):933-9. PubMed ID: 10070893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of integrin alpha3 expression associated with acquisition of invasive potential by ovarian clear cell adenocarcinoma cells.
    Suzuki N; Higashiguchi A; Hasegawa Y; Matsumoto H; Oie S; Orikawa K; Ezawa S; Susumu N; Miyashita K; Aoki D
    Hum Cell; 2005 Sep; 18(3):147-55. PubMed ID: 17022147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer.
    Shigemasa K; Tian X; Gu L; Tanimoto H; Underwood LJ; O'Brien TJ; Ohama K
    Oncol Rep; 2004 Jun; 11(6):1153-9. PubMed ID: 15138549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RECQL1 DNA repair helicase: a potential therapeutic target and a proliferative marker against ovarian cancer.
    Sanada S; Futami K; Terada A; Yonemoto K; Ogasawara S; Akiba J; Yasumoto M; Sumi A; Ushijima K; Kamura T; Furuichi Y; Yano H
    PLoS One; 2013; 8(8):e72820. PubMed ID: 23951333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the chromatin remodeling factor Rsf-1 is upregulated in ovarian carcinoma effusions and predicts poor survival.
    Davidson B; Trope' CG; Wang TL; Shih IeM
    Gynecol Oncol; 2006 Dec; 103(3):814-9. PubMed ID: 16844205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deregulation of sialidases in human normal and tumor tissues.
    Forcella M; Mozzi A; Stefanini FM; Riva A; Epistolio S; Molinari F; Merlo E; Monti E; Fusi P; Frattini M
    Cancer Biomark; 2018 Feb; 21(3):591-601. PubMed ID: 29278877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cloning and biochemical characterization of sialidases from zebrafish (Danio rerio).
    Manzoni M; Colombi P; Papini N; Rubaga L; Tiso N; Preti A; Venerando B; Tettamanti G; Bresciani R; Argenton F; Borsani G; Monti E
    Biochem J; 2007 Dec; 408(3):395-406. PubMed ID: 17708749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homology modeling of human sialidase enzymes NEU1, NEU3 and NEU4 based on the crystal structure of NEU2: hints for the design of selective NEU3 inhibitors.
    Magesh S; Suzuki T; Miyagi T; Ishida H; Kiso M
    J Mol Graph Model; 2006 Oct; 25(2):196-207. PubMed ID: 16427342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features.
    Zuberi M; Mir R; Das J; Ahmad I; Javid J; Yadav P; Masroor M; Ahmad S; Ray PC; Saxena A
    Clin Transl Oncol; 2015 Oct; 17(10):779-87. PubMed ID: 26063644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sialidase NEU3 defines invasive potential of human glioblastoma cells by regulating calpain-mediated proteolysis of focal adhesion proteins.
    Takahashi K; Proshin S; Yamaguchi K; Yamashita Y; Katakura R; Yamamoto K; Shima H; Hosono M; Miyagi T
    Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt A):2778-2788. PubMed ID: 28760640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subtype specific elevated expression of hyaluronidase-1 (HYAL-1) in epithelial ovarian cancer.
    Yoffou PH; Edjekouane L; Meunier L; Tremblay A; Provencher DM; Mes-Masson AM; Carmona E
    PLoS One; 2011; 6(6):e20705. PubMed ID: 21695196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the protease inhibitor antileukoprotease and the serine protease stratum corneum chymotryptic enzyme (SCCE) is coordinated in ovarian tumors.
    Shigemasa K; Tanimoto H; Underwood LJ; Parmley TH; Arihiro K; Ohama K; O'Brien TJ
    Int J Gynecol Cancer; 2001; 11(6):454-61. PubMed ID: 11906548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced expression of membrane-associated sialidase Neu3 decreases GD3 and increases GM3 on the surface of Jurkat cells during etoposide-induced apoptosis.
    Azuma Y; Sato H; Higai K; Matsumoto K
    Biol Pharm Bull; 2007 Sep; 30(9):1680-4. PubMed ID: 17827720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene amplification and protein overexpression of MET are common events in ovarian clear-cell adenocarcinoma: their roles in tumor progression and prognostication of the patient.
    Yamamoto S; Tsuda H; Miyai K; Takano M; Tamai S; Matsubara O
    Mod Pathol; 2011 Aug; 24(8):1146-55. PubMed ID: 21478826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in expression pattern of splicing factors in epithelial ovarian cancer and its clinical impact.
    Iborra S; Hirschfeld M; Jaeger M; Zur Hausen A; Braicu I; Sehouli J; Gitsch G; Stickeler E
    Int J Gynecol Cancer; 2013 Jul; 23(6):990-6. PubMed ID: 23748175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of endogenous sialidases of human monocytes during cellular differentiation into macrophages.
    Stamatos NM; Liang F; Nan X; Landry K; Cross AS; Wang LX; Pshezhetsky AV
    FEBS J; 2005 May; 272(10):2545-56. PubMed ID: 15885103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.